Safety of antivascular endothelial growth factor administration in the ocular anterior segment in pterygium and neovascular glaucoma treatment: Systematic review and meta-analysis

Medicine
Shi-Tong HuangShi-You Zhou

Abstract

Anti-VEGF agents has been widely used in ocular diseases, but its safety for treating anterior segment disorders, the conclusions are controversial. Several major databases, including CENTRAL, MEDLINE, and EMBASE, were searched. Safety data from 18 randomized controlled trials (RCTs) were used to compare anti-VEGF treatment in the ocular anterior segment in pterygium and neovascular glaucoma treatment with placebo/sham treatment for eye diseases. A meta-analysis for adverse events was performed. Eighteen RCT studies with 955 eyes were included in the meta-analysis. Significant difference in conjunctival disorders (OR: 1.62; 95% CI, 1.01-2.59; P = .05) was noted among the included studies, but not in ocular intolerance (odds ratio [OR]: 0.75; 95% CI, 0.34-1.62; P = .46), corneal disorders (OR: 0.71; 95% CI, 0.37-1.37; P = .31), or the subgroup analysis of conjunctival disorders. The administration of anti-VEGF agents in the ocular anterior segment for patients with pterygium and glaucoma was tolerable in tolerance and cornea, but was the risk factor of conjunctival disorders. The healing of corneal epithelium may be delayed in patients with primary corneal epithelial defects after anti-VEGF application. However, due to the limit...Continue Reading

References

Aug 28, 2007·Cornea·Efdal YoeruekPeter Szurman
Apr 29, 2008·Ophthalmology·Sang Woo KimTae-im Kim
May 20, 2008·Investigative Ophthalmology & Visual Science·Charles Q YuMark I Rosenblatt
Jan 20, 2009·Investigative Ophthalmology & Visual Science·Felix BockClaus Cursiefen
May 6, 2009·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Yanyan KoenigClaus Cursiefen
Nov 6, 2009·Ophthalmic Research·Mohammad Reza RazeghinejadHossein Eghbal
Apr 16, 2010·Investigative Ophthalmology & Visual Science·Eun Chul KimMan Soo Kim
Oct 28, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Mohammad BanifatemiAhmadreza Gholampour
May 29, 2012·Current Opinion in Ophthalmology·Irit BaharAllan Slomovic
Aug 14, 2012·Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye·Maha M ShahinMohamed M Elwan
Oct 26, 2013·The British Journal of Ophthalmology·Evelien VandewalleIngeborg Stalmans
Mar 8, 2014·British Journal of Clinical Pharmacology·Tsong Qiang Kwong, Moin Mohamed
Sep 28, 2015·Clinical Therapeutics·Ngamjit KasetsuwanVannarut Satitpitakul
Dec 5, 2015·Korean Journal of Ophthalmology : KJO·Shinyoung Hwang, Sangkyung Choi

❮ Previous
Next ❯

Software Mentioned

Cochrane Risk Bias
SPSS
Ovid

Related Concepts

Related Feeds

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.